Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TCTR20251222015Phase 4Not yet recruiting
Phase 4, randomised trial of dexmedetomidine in surgical stress (2 arms), sponsored by King Chulalongkorn Memorial Hospital. Primary endpoint: Arterial lactate level at end of surgery. Planned start Dec 2025; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on TCTR20251222015.